F. Guillemin, A. Saraux, P. Guggenbuhl, C. Roux, P. Fardellone et al., Prevalence of rheumatoid arthritis in France: 2001, Annals of the Rheumatic Diseases, vol.64, issue.10, pp.1427-1457, 2001.
DOI : 10.1136/ard.2004.029199

Y. Alamanos, P. Voulgari, and A. Drosos, Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review182-8. 3. van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis, Semin. Arthritis Rheum. Br J Rheumatol, vol.3634, issue.3 2, pp.74-82, 1995.

D. Aletaha, T. Neogi, A. Silman, J. Funovits, D. Felson et al., 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1580-1588, 2010.
DOI : 10.1136/ard.2010.138461

URL : https://hal.archives-ouvertes.fr/hal-01557559

V. Strand and D. Khanna, The impact of rheumatoid arthritis and treatment on patients' lives, Clin. Exp. Rheumatol, vol.28, issue.3, pp.32-40, 2010.

V. Strand, V. Sharp, A. Koenig, G. Park, Y. Shi et al., Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment, Annals of the Rheumatic Diseases, vol.71, issue.7, pp.1143-50, 2012.
DOI : 10.1136/annrheumdis-2011-200387

S. Dadoun, S. Lucier, D. Rosa, M. Saraux, A. Berenbaum et al., Rheumatoid Arthritis (RA) Impact on Work and RA-Related Indirect Costs during the First Three Years after RA Diagnosis. An Economic Analysis from the ESPOIR Cohort, Atlanta (GA, 2010.

E. Hallert, M. Björk, O. Dahlström, T. Skogh, and I. Thyberg, Disease activity and disability in women and men with early rheumatoid arthritis (RA): An 8-year followup of a Swedish early RA project 2012 août, Arthritis Care Res, vol.64, issue.8, pp.1101-1108

N. Minaur, R. Jacoby, J. Cosh, G. Taylor, and J. Rasker, Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality, J Rheumatol, vol.69, pp.3-8, 2004.

L. Callahan and P. T. , Mortality in the rheumatic diseases, Arthritis Care & Research, vol.22, issue.4, pp.229-270, 1995.
DOI : 10.7326/0003-4819-73-6-929

A. Kvalvik, M. Jones, and D. Symmons, Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992, Scand J Rheumatol, vol.29, issue.1, pp.29-37, 2000.

D. Kernick, Introduction to health economics for the medical practitioner, Postgraduate Medical Journal, vol.79, issue.929, pp.147-50, 2003.
DOI : 10.1136/pmj.79.929.147

M. Drummond, M. Sculpher, and G. Torrance, Methods for economic evaluation of health care programmes, 2005.

O. 'brien and B. , Principles of economic evaluation for health care programs, J Rheumatol, vol.22, issue.7, pp.1399-402, 1995.

A. Briggs and M. Sculpher, An Introduction to Markov Modelling for Economic Evaluation, PharmacoEconomics, vol.13, issue.4, pp.397-409, 1998.
DOI : 10.2165/00019053-199813040-00003

D. Rice, Cost-of-illness studies: fact or fiction?, The Lancet, vol.344, issue.8936, pp.1519-1539, 1994.
DOI : 10.1016/S0140-6736(94)90342-5

D. Coyle, V. Welch, B. Shea, S. Gabriel, M. Drummond et al., Issues of consensus and debate for economic evaluation in rheumatology, J Rheumatol, vol.28, issue.3, pp.642-649, 2001.

S. Gabriel, P. Tugwell, and M. Drummond, Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology, Annals of the Rheumatic Diseases, vol.61, issue.4, pp.370-373, 2002.
DOI : 10.1136/ard.61.4.370

J. Bridges, Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics, Appl Health Econ Health Policy, vol.2, issue.4, pp.213-237, 2003.

D. Khanna and J. Tsevat, Health-related quality of life--an introduction, Am J Manag Care, vol.13, pp.218-223, 2007.

J. Neumann and O. Morgenstern, Theory of Games and Economic Behavior (Commemorative Edition) Princeton University Press, 2007.

G. Torrance, W. Thomas, and D. Sackett, A utility maximization model for evaluation of health care programs, Health Serv Res, vol.7, issue.2, pp.118-151, 1972.

D. Bell and P. Farquhar, Perspectives on utility theory, Operations Research, pp.179-83, 1986.

M. Weinstein and W. Stason, Foundations of Cost-Effectiveness Analysis for Health and Medical Practices, New England Journal of Medicine, vol.296, issue.13, pp.716-737, 1977.
DOI : 10.1056/NEJM197703312961304

A. Williams, Economics of coronary artery bypass grafting., BMJ, vol.291, issue.6491, pp.326-335
DOI : 10.1136/bmj.291.6491.326

G. Torrance, Measurement of health state utilities for economic appraisal, Journal of Health Economics, vol.5, issue.1, pp.1-30, 1986.
DOI : 10.1016/0167-6296(86)90020-2

C. Bakker and S. Van-der-linden, Health related utility measurement: an introduction, J. Rheumatol, vol.22, issue.6, pp.1197-1206, 1995.
DOI : 10.1016/0738-3991(93)90128-j

M. Puhan, H. Schünemann, E. Wong, L. Griffith, and G. Guyatt, The standard gamble showed better construct validity than the time trade-off, Journal of Clinical Epidemiology, vol.60, issue.10, pp.1029-1062, 2007.
DOI : 10.1016/j.jclinepi.2007.03.001

M. Drummond, G. Stoddart, and G. Torrance, Methods for the economic evaluation of health care programmes, 1987.

D. Froberg and R. Kane, Methodology for measuring health-state preferences???II: Scaling methods, Journal of Clinical Epidemiology, vol.42, issue.5, pp.459-71, 1989.
DOI : 10.1016/0895-4356(89)90136-4

P. Dolan and C. Gudex, Time preference, duration and health state valuations. Health Econ, pp.289-99, 1995.

J. Brazier, J. Roberts, and M. Deverill, The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-92, 2002.
DOI : 10.1016/S0167-6296(01)00130-8

J. Horsman, W. Furlong, D. Feeny, and G. Torrance, The Health Utilities Index (HUI): concepts, measurement properties and applications, Health and Quality of Life Outcomes, vol.1, issue.1, p.54, 2003.
DOI : 10.1186/1477-7525-1-54

P. Dolan, Modeling valuations for EuroQol health states. Med Care, pp.1095-108, 1997.

J. Chevalier and G. De-pouvourville, Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011.

J. Ware, . Jr, and C. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, pp.473-83, 1992.

A. Leplège, E. Ecosse, A. Verdier, and T. Perneger, The French SF-36 Health Survey, Journal of Clinical Epidemiology, vol.51, issue.11, pp.1013-1036, 1998.
DOI : 10.1016/S0895-4356(98)00093-6

R. Carr-hill, Assumptions of the QALY procedure, Social Science & Medicine, vol.29, issue.3, pp.469-77, 1989.
DOI : 10.1016/0277-9536(89)90296-7

J. Moatti, P. Auquier, L. Coroller, A. Macquart-moulin, and G. , [QALYS or not QALYS: that is the question?]. Rev Epidemiol Sante Publique, pp.573-83, 1995.

J. Robine, C. Mathers, and D. Bucquet, Distinguishing health expectancies and health-adjusted life expectancies from quality-adjusted life years., American Journal of Public Health, vol.83, issue.6, pp.797-805, 1993.
DOI : 10.2105/AJPH.83.6.797

F. Guillemin, The value of utility: assumptions underlying preferences and quality adjusted life years, J Rheumatol, vol.26, issue.9, pp.1861-1864, 1999.

M. Van-den-akker, F. Buntinx, J. Metsemakers, S. Roos, and J. Knottnerus, Multimorbidity in General Practice: Prevalence, Incidence, and Determinants of Co-Occurring Chronic and Recurrent Diseases, Journal of Clinical Epidemiology, vol.51, issue.5, pp.367-75, 1998.
DOI : 10.1016/S0895-4356(97)00306-5

M. Fortin, L. Lapointe, C. Hudon, A. Vanasse, A. Ntetu et al., Multimorbidity and quality of life in primary care: a systematic review, Health and Quality of Life Outcomes, vol.2, issue.1, p.51, 2004.
DOI : 10.1186/1477-7525-2-51

M. Harrison, N. Bansback, C. Marra, M. Drummond, P. Tugwell et al., Valuing Health for Clinical and Economic Decisions: Directions Relevant for Rheumatologists, The Journal of Rheumatology, vol.38, issue.8, pp.1770-1775, 2011.
DOI : 10.3899/jrheum.110404

M. Weinstein and W. Stason, Foundations of Cost-Effectiveness Analysis for Health and Medical Practices, New England Journal of Medicine, vol.296, issue.13, pp.716-737, 1977.
DOI : 10.1056/NEJM197703312961304

A. Tsuchiya and P. Dolan, The QALY Model and Individual Preferences for Health States and Health Profiles over Time: A Systematic Review of the Literature, Medical Decision Making, vol.25, issue.4, pp.460-467, 2005.
DOI : 10.1006/jmps.1999.1256

P. Dolan, Modeling Valuations for EuroQol Health States, Medical Care, vol.35, issue.11, pp.1095-1108, 1997.
DOI : 10.1097/00005650-199711000-00002

J. Brazier, J. Roberts, and M. Deverill, The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-292, 2002.
DOI : 10.1016/S0167-6296(01)00130-8

D. Khanna and J. Tsevat, Health-related quality of life--an introduction, Am. J. Manag. Care, vol.13, pp.218-241, 2007.

B. Combe, J. Benessiano, and F. Berenbaum, The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007.
DOI : 10.1016/j.jbspin.2007.06.001

M. Prevoo, M. Van-'t-hof, and H. Kuper, Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.20, issue.1, pp.44-48, 1995.
DOI : 10.1002/art.1780281203

J. Fries, P. Spitz, and R. Kraines, Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-182, 1980.
DOI : 10.1001/jama.1963.03060120024016

G. Barton, T. Sach, and A. Avery, A comparison of the performance of the EQ???5D and SF???6D for individuals aged ??? 45 years, Health Economics, vol.30, issue.2, pp.815-832, 2008.
DOI : 10.3310/hta9320

J. Chevalier and G. De-pouvourville, Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011.

S. Macran and P. Kind, ???Death??? and the Valuation of Health-Related Quality of Life, Medical Care, vol.39, issue.3, pp.217-244, 2001.
DOI : 10.1097/00005650-200103000-00003

D. Wit, G. Busschbach, J. , D. Charro, and F. , Sensitivity and perspective in the valuation of health status: whose values count?, Health Economics, vol.13, issue.2, pp.109-135, 2000.
DOI : 10.1177/0272989X9301300210

M. Harrison, L. Davies, N. Bansback, M. Mccoy, T. Farragher et al., Why Do Patients with Inflammatory Arthritis Often Score States ???Worse than Death??? on the EQ-5D? An Investigation of the EQ-5D Classification System, Value in Health, vol.12, issue.6, pp.1026-1060, 2009.
DOI : 10.1111/j.1524-4733.2009.00565.x

R. Adams, C. Walsh, and D. Veale, Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis, PharmacoEconomics, vol.26, issue.9, pp.477-87, 2010.
DOI : 10.1093/rheumatology/35.suppl_2.4

X. Badia, M. Roset, M. Herdman, and P. Kind, A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States, Medical Decision Making, vol.18, issue.1, pp.7-16, 2001.
DOI : 10.1002/(SICI)1099-1050(199909)8:6<541::AID-HEC464>3.0.CO;2-8

A. Tsuchiya, S. Ikeda, N. Ikegami, S. Nishimura, I. Sakai et al., Estimating an EQ-5D population value set: the case of Japan, Health Economics, vol.51, issue.4, pp.341-53, 2002.
DOI : 10.1016/S0895-4356(98)00095-X

G. Apolone, D. Carli, G. Brunetti, M. Garattini, and S. , Health-Related Quality of Life (HR-QOL) and Regulatory Issues, PharmacoEconomics, vol.279, issue.6, pp.187-95, 2001.
DOI : 10.2165/00019053-200119020-00005

. Van-der-heijde, 97 EQ-5D score ACR/EULAR criteria for rheumatoid arthritis, no. (%) 0

. France, positive > 50 U/ml) detected in all patients by the same technique in a central lab

$. Van-der-heijde, 3%) had erosions on hands and/or feet at baseline. 1.98±0, p.160

P. Dolan, Modeling Valuations for EuroQol Health States, Medical Care, vol.35, issue.11, pp.1095-1108, 1997.
DOI : 10.1097/00005650-199711000-00002

J. Brazier, J. Roberts, and M. Deverill, The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-292, 2002.
DOI : 10.1016/S0167-6296(01)00130-8

D. Khanna and J. Tsevat, Health-related quality of life--an introduction, Am. J. Manag. Care, vol.13, pp.218-241, 2007.

A. Tsuchiya and P. Dolan, The QALY Model and Individual Preferences for Health States and Health Profiles over Time: A Systematic Review of the Literature, Medical Decision Making, vol.25, issue.4, pp.460-467, 2005.
DOI : 10.1006/jmps.1999.1256

B. Conner-spady and M. Suarez-almazor, Variation in the Estimation of Quality-adjusted Life-years by Different Preference-based Instruments, Medical Care, vol.41, issue.7, pp.791-801, 2003.
DOI : 10.1097/00005650-200307000-00003

S. Lillegraven, I. Kristiansen, and T. Kvien, Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.10
DOI : 10.1136/ard.2009.124099

F. Xie, S. Li, N. Luo, N. Lo, S. Yeo et al., Comparison of the EuroQol and short form 6D in Singapore multiethnic asian knee osteoarthritis patients scheduled for total knee replacement, Arthritis & Rheumatism, vol.22, issue.6, pp.1043-1052, 2007.
DOI : 10.1016/S0140-6736(86)90837-8

C. Marra, J. Esdaile, D. Guh, J. Kopec, J. Brazier et al., A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis, Medical Care, vol.42, issue.11, pp.1125-1131, 2004.
DOI : 10.1097/00005650-200411000-00012

G. Barton, T. Sach, A. Avery, C. Jenkinson, M. Doherty et al., A comparison of the performance of the EQ???5D and SF???6D for individuals aged ??? 45 years, Health Economics, vol.30, issue.2, pp.815-832, 2008.
DOI : 10.3310/hta9320

C. Gaujoux-viala, A. Rat, F. Guillemin, R. Flipo, P. Fardellone et al., Comparison of the EQ-5D and the Short Form 6D utility measures in French patients with early arthritis: Results from the ESPOIR cohort, J Rheumatol, 2011.

B. Combe, J. Benessiano, F. Berenbaum, A. Cantagrel, J. Daures et al., The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007.
DOI : 10.1016/j.jbspin.2007.06.001

M. Prevoo, M. Van-'t-hof, H. Kuper, M. Van-leeuwen, L. Van-de-putte et al., Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.20, issue.1
DOI : 10.1002/art.1780281203

J. Fries, P. Spitz, R. Kraines, and H. Holman, Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-182, 1980.
DOI : 10.1001/jama.1963.03060120024016

F. Guillemin, J. Coste, J. Pouchot, M. Ghezail, and C. Bregeon, Sany J, and the French Quality of Life in Rheumatology Group. The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2, Arthritis Rheum, vol.40, pp.1267-74, 1997.

J. Ware, . Jr, and C. Sherbourne, The MOS 36-item short-form health survey (SF-36

S. Walters and J. Brazier, Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D, Quality of Life Research, vol.2, issue.5, pp.1523-1555, 2005.
DOI : 10.1136/bmj.316.7139.1236

P. Gandhi, L. Ried, A. Bibbey, and I. Huang, SF-6D utility index as measure of minimally important difference in health status change, Journal of the American Pharmacists Association, vol.52, issue.1, pp.34-42, 2003.
DOI : 10.1331/JAPhA.2012.10114

P. Dolan, C. Gudex, P. Kind, and A. Williams, Valuing health states: A comparison of methods, Journal of Health Economics, vol.15, issue.2
DOI : 10.1016/0167-6296(95)00038-0

A. Tsuchiya, J. Brazier, and J. Roberts, Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets, Journal of Health Economics, vol.25, issue.2, pp.334-346, 2006.
DOI : 10.1016/j.jhealeco.2005.09.003

C. Gaujoux-viala, B. Fautrel, F. Guillemin, R. Flipo, P. Bourgeois et al., Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort, Rheumatology, vol.19, issue.2
DOI : 10.2165/00019053-200119020-00005

URL : https://hal.archives-ouvertes.fr/hal-01044491

M. Harrison, L. Davies, N. Bansback, M. Mccoy, T. Farragher et al., Why Do Patients with Inflammatory Arthritis Often Score States ???Worse than Death??? on the EQ-5D? An Investigation of the EQ-5D Classification System, Value in Health, vol.12, issue.6, pp.1026-1060, 2009.
DOI : 10.1111/j.1524-4733.2009.00565.x

J. Brazier, J. Roberts, A. Tsuchiya, and J. Busschbach, A comparison of the EQ-5D and SF-6D across seven patient groups, Health Economics, vol.13, issue.9, pp.873-884, 2004.
DOI : 10.1002/hec.866

J. Chevalier and G. De-pouvourville, Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011.

>. France-;-positive, DiaSorin, France; positive > 50 U/ml) were detected in all patients using the same technique in a central lab

S. Hospital, ,. , ?. Eemois, F. 3. Paris, I. et al., France Key words: utility, SF-6D, early arthritis Institutions to which the work should be attributed

C. Gaujoux-viala, M. , A. Rat, . Md, K. Phd et al., MD, PhD Corresponding author: Dr Cécile Gaujoux-Viala, pp.33-34

6. , .. Haq, and A. , -mental scores explained 49.3 and 14.5% of the variance respectively (table 3) At 6 months visit and further time-points, the determinants of SF-6D were almost the same. Compared to baseline results, the part of the variance they explained dramatically changed (Figure 1). HAQ and AIMS2-SF-mental scores

G. Torrance, Measurement of health state utilities for economic appraisal, Journal of Health Economics, vol.5, issue.1, pp.1-30, 1986.
DOI : 10.1016/0167-6296(86)90020-2

M. Weinstein and W. Stason, Foundations of Cost-Effectiveness Analysis for Health and Medical Practices, New England Journal of Medicine, vol.296, issue.13, pp.716-737, 1977.
DOI : 10.1056/NEJM197703312961304

C. Bakker and S. Van-der-linden, Health related utility measurement: an introduction, J. Rheumatol, vol.22, issue.6, pp.1197-1206, 1995.

M. Drummond, M. Sculpher, and G. Torrance, Methods for economic evaluation of health care programmes, 2005.

J. Brazier, J. Roberts, and M. Deverill, The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-92, 2002.
DOI : 10.1016/S0167-6296(01)00130-8

D. Khanna and J. Tsevat, Health-related quality of life--an introduction, Am J Manag Care, vol.13, pp.218-223, 2007.

S. Lillegraven, I. Kristiansen, and T. Kvien, Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.10
DOI : 10.1136/ard.2009.124099

C. Marra, S. Marion, D. Guh, M. Najafzadeh, F. Wolfe et al., Not all ???quality-adjusted life years??? are equal, Journal of Clinical Epidemiology, vol.60, issue.6, pp.616-640, 2007.
DOI : 10.1016/j.jclinepi.2006.09.006

C. Gaujoux-viala, A. Rat, F. Guillemin, R. Flipo, P. Fardellone et al., Comparison of the EQ-5D and the SF-6D Utility Measures in 813 Patients with Early Arthritis: Results from the ESPOIR Cohort, The Journal of Rheumatology, vol.38, issue.8, pp.1576-84, 2011.
DOI : 10.3899/jrheum.101006

URL : https://hal.archives-ouvertes.fr/hal-00790808

N. Bansback, C. Marra, A. Tsuchiya, A. Anis, D. Guh et al., Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Rheum, août, vol.1557, issue.6, pp.963-71, 2007.

J. Brazier, Y. Yang, A. Tsuchiya, and D. Rowen, A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures, The European Journal of Health Economics, vol.22, issue.2
DOI : 10.1177/02729890122062352

D. Fryback, E. Dasbach, R. Klein, B. Klein, N. Dorn et al., The Beaver Dam Health Outcomes study, Medical Decision Making, vol.23, issue.2, pp.89-102, 1993.
DOI : 10.1016/S0161-6420(91)32137-7

B. Combe, J. Benessiano, F. Berenbaum, A. Cantagrel, J. Daures et al., The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007.
DOI : 10.1016/j.jbspin.2007.06.001

M. Prevoo, M. Van-'t-hof, H. Kuper, M. Van-leeuwen, L. Van-de-putte et al., Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.20, issue.1, pp.44-52, 1995.
DOI : 10.1002/art.1780281203

J. Fries, P. Spitz, R. Kraines, and H. Holman, Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-182, 1980.
DOI : 10.1001/jama.1963.03060120024016

F. Guillemin, J. Coste, J. Pouchot, M. Ghézail, C. Bregeon et al., The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group, Arthritis Rheum, vol.40, issue.7, pp.1267-74, 1997.

P. Dolan, Modeling valuations for EuroQol health states. Med Care, pp.1095-108, 1997.

J. Ware, . Jr, and C. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, pp.473-83, 1992.

S. Walters and J. Brazier, Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D, Quality of Life Research, vol.2, issue.5, pp.1523-1555, 2005.
DOI : 10.1136/bmj.316.7139.1236

P. Gandhi, L. Ried, A. Bibbey, and I. Huang, SF-6D utility index as measure of minimally important difference in health status change, Journal of the American Pharmacists Association, vol.52, issue.1, pp.34-42, 2003.
DOI : 10.1331/JAPhA.2012.10114

C. Gaujoux-viala, B. Fautrel, F. Guillemin, R. Flipo, P. Bourgeois et al., Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort, Rheumatology, vol.19, issue.2
DOI : 10.2165/00019053-200119020-00005

URL : https://hal.archives-ouvertes.fr/hal-01044491

J. Brazier, J. Roberts, A. Tsuchiya, and J. Busschbach, A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ, pp.873-84, 2004.

P. Barton, P. Jobanputra, J. Wilson, S. Bryan, and A. Burls, The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis, Health Technology Assessment, vol.8, issue.11, pp.1-91, 2004.
DOI : 10.3310/hta8110

A. Brennan, N. Bansback, A. Reynolds, and P. Conway, Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK. Rheumatology (Oxford), pp.62-72, 2004.

S. Amjadi, P. Maranian, H. Paulus, R. Kaplan, V. Ranganath et al., Validating and Assessing the Sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in Patients with Early Aggressive Rheumatoid Arthritis, The Journal of Rheumatology, vol.36, issue.6, pp.1150-1157, 2009.
DOI : 10.3899/jrheum.080959

D. Scott, B. Khoshaba, E. Choy, and G. Kingsley, Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ, Annals of the Rheumatic Diseases, vol.66, issue.11, pp.1534-1541, 2007.
DOI : 10.1136/ard.2007.073726

M. Harrison, M. Lunt, S. Verstappen, K. Watson, N. Bansback et al., Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis, Health and Quality of Life Outcomes, vol.8, issue.1, p.21, 2010.
DOI : 10.1186/1477-7525-8-21

J. Chevalier and G. De-pouvourville, Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011.

*. Baseline and C. , IgM and IgA rheumatoid factor (Elisa, Menarini, France; positive >9 UI/ml) and anti-CCP2 antibodies (ELISA, DiaSorin, France; positive > 50 U/ml) were detected in all patients using the same technique in a central lab